Portable Medical Technology launches decision-support app for
7 February 2013
Portable Medical Technology has launched ONCOassist, a new
smartphone app developed specifically for oncologists to bring vital
clinical decision support tools to their mobile device.
Traditionally, oncologists have spent many hours searching for
academic papers and complex formulae online.
will eliminate this repetitive time consuming task by delivering
oncologists the required clinical decision support tools at the
point of care, and save time searching.
Dr Richard Bambury, Eoin O’Carroll and Kevin Bambury are the
founders of ONCOassist. All graduates of University College Cork in
Ireland, the team were recently selected out of hundreds of other
applicants as a high potential startup company to participate in the
prestigious Healthbox Europe startup accelerator, located in central
Dr Bambury, a specialist registrar in medical oncology working at
Memorial Sloan Kettering Cancer Center in New York, became acutely
aware of the need for a point-of-care application designed
specifically for oncologists and teamed up with his brother Kevin
and Eoin O’Carroll to develop the application.
“I saw a pressing need for a high-technology mobile application
that offered me all the tools I needed as I did my rounds,” said
Bambury. “For example, in order to assess how much benefit patients
are likely to receive from chemotherapy, we have traditionally used
estimates based on prior clinical trial data that may or may not be
applicable to each patient. There are a limited number of online
tools available to help with this, but none of these are in
ONCOassist is only the first Irish and third company worldwide to
take the step of getting a CE mark, which is the European Union
quality control regulation analogous to the FDA in the US.
“As our application falls within the definition of a medical
device, we felt having a CE mark was of the utmost importance in
order to demonstrate compliance with Regulatory Requirements” said
Currently available in the AppStore for download to the iPhone
and iPad in the UK and Ireland, the company plans to roll out the
platform for use on android devices by Q3-4 2013.
For more information see: